Consistent with the above finding, several studies in colon cancer revealed an association between p21 downregulation and metastasis as well as poor survival [30], [31], [32], [33], however, some reports point towards a dual role in several cancers with increase of p21 correlating with poor outcome [34], [35]. Here, CDKN1A is linked to malignant colon neoplasm.